Many of the well-established tau PET tracers were developed for AD and demonstrate limited utility for imaging non-AD tauopathies (e.g. progressive supranuclear palsy, corticobasal degeneration, chronic traumatic encephalopathy, Pick's disease, etc). Here, MAPT is linked to Alzheimer disease.